MedPath

A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia

Withdrawn
Conditions
Malignant Hyperthermia
Registration Number
NCT02561598
Lead Sponsor
Children's Hospital Medical Center, Cincinnati
Brief Summary

The purpose of the study is to develop methods to identify predictors of Malignant Hyperthermia.

Detailed Description

The current study will use the combination of electronic medical records and genomic information in samples of persons who have exhibited signs of Malignant Hyperthermia (MH) or have family history or high risk of MH to see if risk factors can be identified. These will be compared with control samples of children who have been exposed to the same agents which could induce MH, yet showed no signs of the disorder.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Malignant hyperthermia cases: Diagnosis of malignant hyperthermia
  • Control cases: children who participated
Exclusion Criteria
  • Not meeting the inclusion criteria stated above

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of clinical manifestations of malignant hyperthermiaWithin data collection period (3 years total).

Incidence of clinical manifestations of MH will be compared among patients with a history of MH to controls (no diagnosis of MH).

Secondary Outcome Measures
NameTimeMethod
number of Genetic indications for malignant hyperthermiaWithin data collection period (3 years total).

genetic indications for malignant hyperthermia will be compared between control subjects and subjects with a diagnosis of MH

Trial Locations

Locations (1)

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath